Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms

被引：1

作者：

Tashi, Tsewang ^{[1
]}

Deininger, Michael W. ^{[2
]}

机构：

[1] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, 2000 Circle Hope, Salt Lake City, UT 84112 USA

[2] Med Coll Wisconsin, Versiti Blood Res Inst, Div Hematol & Oncol, 8727 West Water town Plank Rd, Milwaukee, WI 53226 USA

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2023年 / 43卷 / 04期

关键词：

Systemic mastocytosis; Associated hematologic neoplasm; KIT D816 V; KIT inhibitors; Tryptase; Avapritinib; MAST-CELL DISORDERS; C-KIT MUTATION; IMATINIB MESYLATE; TREATMENT OPTIONS; TYROSINE KINASE; RESPONSE CRITERIA; INTERFERON-ALPHA; TRYPTASE LEVELS; LEUKEMIA; EFFICACY;

D O I：

10.1016/j.iac.2023.04.009

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：723 / 741

页数：19

共 86 条

[1] A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib [J].

Akin, C ;

Fumo, G ;

Yavuz, AS ;

Lipsky, PE ;

Neckers, L ;

Metcalfe, DD .

BLOOD, 2004, 103 (08) :3222-3225

[2] Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature [J].

Alvarez-Twose, Ivan ;

Matito, Almudena ;

Mario Morgado, Jose ;

Sanchez-Munoz, Laura ;

Jara-Acevedo, Maria ;

Garcia-Montero, Andres ;

Mayado, Andrea ;

Caldas, Carolina ;

Teodosio, Cristina ;

Ignacio Munoz-Gonzalez, Javier ;

Mollejo, Manuela ;

Escribano, Luis ;

Orfao, Alberto .

ONCOTARGET, 2017, 8 (40) :68950-68963

[3] Complete Response After Imatinib Mesylate Therapy in a Patient With Well-Differentiated Systemic Mastocytosis [J].

Alvarez-Twose, Ivan ;

Gonzalez, Pablo .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (12) :E126-E129

[4] International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data [J].

Arber, Daniel A. ;

Orazi, Attilio ;

Hasserjian, Robert P. ;

Borowitz, Michael J. ;

Calvo, Katherine R. ;

Kvasnicka, Hans-Michael ;

Wang, Sa A. ;

Bagg, Adam ;

Barbui, Tiziano ;

Branford, Susan ;

Bueso-Ramos, Carlos E. ;

Cortes, Jorge E. ;

Dal Cin, Paola ;

DiNardo, Courtney D. ;

Dombret, Herve ;

Duncavage, Eric J. ;

Ebert, Benjamin L. ;

Estey, Elihu H. ;

Facchetti, Fabio ;

Foucar, Kathryn ;

Gangat, Naseema ;

Gianelli, Umberto ;

Godley, Lucy A. ;

Gokbuget, Nicola ;

Gotlib, Jason ;

Hellstrom-Lindberg, Eva ;

Hobbs, Gabriela S. ;

Hoffman, Ronald ;

Jabbour, Elias J. ;

Kiladjian, Jean-Jacques ;

Larson, Richard A. ;

Le Beau, Michelle M. ;

Loh, Mignon L. -C. ;

Lowenberg, Bob ;

Macintyre, Elizabeth ;

Malcovati, Luca ;

Mullighan, Charles G. ;

Niemeyer, Charlotte ;

Odenike, Olatoyosi M. ;

Ogawa, Seishi ;

Orfao, Alberto ;

Papaemmanuil, Elli ;

Passamonti, Francesco ;

Porkka, Kimmo ;

Pui, Ching-Hon ;

Radich, Jerald P. ;

Reiter, Andreas ;

Rozman, Maria ;

Rudelius, Martina ;

Savona, Michael R. .

BLOOD, 2022, 140 (11) :1200-1228

[5] Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13 [J].

Bachet, Jean-Baptiste ;

Landi, Bruno ;

Laurent-Puig, Pierre ;

Italiano, Antoine ;

Le Cesne, Axel ;

Levy, Philippe ;

Safar, Violaine ;

Duffaud, Florence ;

Blay, Jean-Yves ;

Emile, Jean-Francois .

EUROPEAN JOURNAL OF CANCER, 2013, 49 (11) :2531-2541

[6] Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis [J].

Barete, Stephane ;

Lortholary, Olivier ;

Damaj, Gandhi ;

Hirsch, Isabelle ;

Chandesris, Marie Olivia ;

Elie, Caroline ;

Hamidou, Mohamed ;

Durieu, Isabelle ;

Suarez, Felipe ;

Grosbois, Bernard ;

Limal, Nicolas ;

Gyan, Emmanuel ;

Larroche, Claire ;

Guillet, Gerard ;

Kahn, Jean Emmanuel ;

Casassus, Philippe ;

Amazzough, Karima ;

Coignard-Biehler, Helene ;

Georgin-Lavialle, Sophie ;

Lhermitte, Ludovic ;

Fraitag, Sylvie ;

Canioni, Danielle ;

Dubreuil, Patrice ;

Hermine, Olivier .

BLOOD, 2015, 126 (08) :1009-1016

[7] Molecular Defects in Mastocytosis KIT and Beyond KIT [J].

Bibi, Siham ;

Langenfeld, Florent ;

Jeanningros, Sylvie ;

Brenet, Fabienne ;

Soucie, Erinn ;

Hermine, Olivier ;

Damaj, Gandhi ;

Dubreuil, Patrice ;

Arock, Michel .

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2014, 34 (02) :239-+

[8] Avapritinib for Systemic Mastocytosis [J].

Bose, Prithviraj ;

Verstovsek, Srdan .

EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (08) :687-696

[9] The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome [J].

Butterfield, Joseph ;

Weiler, Catherine R. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (08) :2533-2541

[10] Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate [J].

Cammenga, J ;

Horn, S ;

Bergholz, U ;

Sommer, G ;

Besmer, P ;

Fiedler, W ;

Stocking, C .

BLOOD, 2005, 106 (12) :3958-3961

← 1 2 3 4 5 6 7 8 9 →